| Literature DB >> 35369045 |
Xiaoyin Chai1, Yin Li2, Zihan Yin1, Fei Wu2, Peiling Hu1, Xiaohui Liu2, Shuhan Tong1, Pan Zhuang3, Yu Zhang3, Weifang Zheng4, Jingjing Jiao2.
Abstract
Background: Although the detrimental effect of red meat on colorectal cancer (CRC) incidence has been extensively reported, no previous studies have comprehensively linked different meat subtypes with colorectal polyp occurrence. The aim was to assess the association of meat and subtypes with colorectal polyp prevalence for the high-risk CRC Chinese population. Besides, we also focused on the association according to sizes, subsites, and multiplicity of polyps.Entities:
Keywords: Lanxi Pre-colorectal Cancer Cohort; colorectal polyps; meat consumption; meat subtypes; poultry consumption
Year: 2022 PMID: 35369045 PMCID: PMC8971953 DOI: 10.3389/fnut.2022.833571
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
FIGURE 1Flow chart of study participants in the current LP3C study.
Baseline characteristics of study participants according to quartiles of meat consumption (n = 6783).
| Quartiles of meat consumption (g⋅2,000 kcal–1⋅d–1) | |||||
|
| |||||
| Characteristics | Q1 | Q2 | Q3 | Q4 | |
|
| 1,695 | 1,696 | 1,696 | 1,696 | |
| Age, | 61.2 ± 0.2 | 59.9 ± 0.2 | 59.6 ± 0.2 | 58.4 ± 0.2 |
|
| Sex, |
| ||||
| Male | 808 (47.7) | 878 (51.8) | 913 (53.8) | 899 (53.0) | |
| Female | 887 (52.3) | 818 (48.2) | 783 (46.2) | 797 (47.0) | |
| Family history of colorectal cancer, | 0.142 | ||||
| No | 1519 (89.6) | 1510 (89.0) | 1487 (87.7) | 1524 (89.9) | |
| Yes | 105 (6.2) | 121 (7.1) | 124 (7.3) | 118 (7.0) | |
| Body mass index, | 23.3 ± 0.1 | 23.5 ± 0.1 | 23.5 ± 0.1 | 23.5 ± 0.1 | 0.107 |
| <18.5, | 940 (55.5) | 909 (53.6) | 919 (54.2) | 936 (55.2) | |
| 18.5–24.0, | 89 (5.3) | 63 (3.7) | 76 (4.5) | 61 (3.6) | |
| 24.0–28, | 542 (32.0) | 596 (35.1) | 562 (33.1) | 571 (33.7) | |
| >28, | 124 (7.3) | 128 (7.6) | 139 (8.2) | 128 (7.6) | |
| Married, | 1511 (89.1) | 1573 (92.8) | 1602 (94.5) | 1610 (94.9) |
|
| ≥High school, | 150 (8.9) | 248 (14.6) | 257 (15.2) | 291 (17.2) |
|
| Household income (yuan/yr), |
| ||||
| <30 thousand | 735 (43.4) | 515 (30.4) | 487 (28.7) | 454 (26.8) | |
| 30–100 thousand | 722 (42.6) | 820 (48.4) | 810 (47.8) | 786 (46.3) | |
| >100 thousand | 238 (14.0) | 361 (21.3) | 399 (23.5) | 456 (26.9) | |
| Physical activity (MET-h/wk) | 175.5 ± 2.9 | 178.2 ± 2.9 | 180.1 ± 2.8 | 190.8 ± 2.9 |
|
| Q1, | 455 (26.8) | 449 (26.5) | 426 (25.1) | 377 (22.2) | |
| Q2, | 421 (24.8) | 437 (25.8) | 413 (24.4) | 418 (24.7) | |
| Q3, | 430 (25.4) | 402 (23.7) | 427 (25.2) | 440 (25.9) | |
| Q4, | 389 (23.0) | 408 (24.1) | 430 (25.4) | 461 (27.2) | |
| Smoking status, | 0.329 | ||||
| Never | 1154 (68.1) | 1103 (65.0) | 1099 (64.8) | 1095 (64.6) | |
|
| |||||
| <500/y | 117 (6.9) | 132 (7.8) | 142 (8.4) | 131 (7.7) | |
| >=500/y | 88 (5.2) | 105 (6.2) | 81 (4.8) | 112 (6.6) | |
|
| |||||
| <500/y | 133 (7.9) | 135 (8.0) | 145 (8.6) | 145 (8.6) | |
| >=500/y | 203 (12.0) | 221 (13.0) | 229 (13.5) | 213 (12.6) | |
| Alcohol drinker, |
| ||||
| Never | 1017 (60.0) | 900 (53.1) | 890 (52.5) | 922 (54.4) | |
| <=25 ml for men, <=15 ml for women | 97 (5.7) | 129 (7.6) | 136 (8.0) | 152 (9.0) | |
| >25 ml for men, >15 ml for women | 581 (34.3) | 667 (39.3) | 670 (39.5) | 622 (36.7) | |
| Vitamin supplement intake, | 0.057 | ||||
| No | 1681 (99.2) | 1689 (99.6) | 1684 (99.3) | 1675 (98.8) | |
| Yes | 14 (0.8) | 7 (0.4) | 12 (0.7) | 21 (1.2) | |
| Calcium supplement intake, | 0.904 | ||||
| No | 1604 (94.6) | 1610 (94.9) | 1605 (94.6) | 1613 (95.1) | |
| Yes | 91 (5.4) | 86 (5.1) | 91 (5.4) | 83 (4.9) | |
| Regular aspirin use, | 0.796 | ||||
| No | 1676 (98.9) | 1681 (99.1) | 1683 (99.2) | 1677 (98.9) | |
| Yes | 19 (1.1) | 14 (0.8) | 12 (0.7) | 18 (1.1) | |
| History of hypertension, | 491 (29.0) | 462 (27.2) | 425 (25.1) | 368 (21.7) |
|
| Cardiovascular disease, | 18 (1.1) | 24 (1.4) | 11 (0.7) | 9 (0.5) |
|
| Cancer, | 20 (1.2) | 19 (1.1) | 18 (1.1) | 24 (1.4) | 0.792 |
| Diabetes, | 103 (6.1) | 100 (5.9) | 94 (5.5) | 99 (5.8) | 0.662 |
|
| |||||
| Total energy (kcal–1⋅d–1) | 1916.6 ± 18.3 | 2034.5 ± 17.6 | 2054.8 ± 15.5 | 2057.2 ± 14.5 |
|
| Grain (g⋅2,000 kcal–1⋅d–1) | 440.3 ± 2.1 | 414.2 ± 2.0 | 398.4 ± 1.6 | 357.7 ± 1.6 |
|
| Refined grain (g⋅2,000 kcal–1⋅d–1) | 434.8 ± 2.1 | 409.3 ± 2.0 | 394.3 ± 1.6 | 352.4 ± 1.5 |
|
| Dairy products (g⋅2,000 kcal–1⋅d–1) | 37.0 ± 2.1 | 34.6 ± 2.0 | 29.0 ± 1.6 | 29.8 ± 1.6 |
|
| Total meat (g⋅2,000 kcal–1⋅d–1) | 23.2 ± 0.3 | 57.1 ± 0.2 | 91.7 ± 0.3 | 164.0 ± 1.2 |
|
| Red meat (g⋅2,000 kcal–1⋅d–1) | 13.9 ± 0.2 | 38.5 ± 0.4 | 68.5 ± 0.5 | 128.6 ± 1.3 |
|
| Unprocessed red meat (g⋅2,000 kcal–1⋅d–1) | 13.6 ± 0.2 | 37.9 ± 0.4 | 67.9 ± 0.5 | 127.5 ± 1.3 |
|
| Processed red meat (g⋅2,000 kcal–1⋅d–1) | 0.33 ± 0.02 | 0.51 ± 0.04 | 0.61 ± 0.04 | 1.12 ± 0.14 |
|
| Poultry (g⋅2,000 kcal–1⋅d–1) | 2.5 ± 0.1 | 4.6 ± 0.1 | 5.9 ± 0.2 | 9.5 ± 0.4 |
|
| Seafood (g⋅2,000 kcal–1⋅d–1) | 6.8 ± 0.2 | 14.0 ± 0.3 | 17.3 ± 0.4 | 26.4 ± 0.7 |
|
| Vegetables (g⋅2,000 kcal–1⋅d–1) | 243.5 ± 2.7 | 231.8 ± 2.4 | 224.3 ± 2.3 | 220.4 ± 2.3 |
|
| Preserved vegetables (g⋅2,000 kcal–1⋅d–1) | 4.2 ± 0.2 | 3.8 ± 0.2 | 3.4 ± 0.2 | 3.8 ± 0.3 | 0.161 |
| Fruit (g⋅2,000 kcal–1⋅d–1) | 94.4 ± 3.3 | 101.2 ± 2.3 | 105.1 ± 2.3 | 111.0 ± 2.3 |
|
Multivariable-adjusted ORs (95% CIs) of meat consumption with the prevalence of colorectal polyps.
| Quartiles of meat consumption (g⋅2,000 kcal–1⋅d–1) | |||||
|
| |||||
| Risk factors | Q1 | Q2 | Q3 | Q4 | |
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 24.2 (<40.7) | 57.0 (40.7–73.6) | 91.5 (73.6–111.7) | 147.5 (≥111.7) | |
| Cases/ | 515/1,695 | 497/1,696 | 536/1,696 | 516/1,696 | |
| Model 1 | 1 (ref) | 0.96 (0.82–1.12) | 1.08 (0.92–1.25) | 1.08 (0.93–1.26) | 0.16 |
| Model 2 | 1 (ref) | 0.94 (0.80–1.10) | 1.08 (0.92–1.26) | 1.08 (0.93–1.27) | 0.13 |
| Model 3 | 1 (ref) | 0.94 (0.81–1.10) | 1.08 (0.93–1.26) | 1.09 (0.93–1.28) | 0.12 |
| Model 4 | 1 (ref) | 0.94 (0.80–1.09) | 1.08 (0.92–1.26) | 1.09 (0.93–1.28) | 0.11 |
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 11.0 (<22.1) | 35.7 (22.1–51.3) | 68.8 (51.3–86.2) | 116.8 (≥86.2) | |
| Cases/n | 528/1,695 | 496/1,696 | 536/1,696 | 504/1,696 | |
| Model 1 | 1 (ref) | 0.93 (0.80–1.08) | 1.00 (0.86–1.16) | 0.97 (0.83–1.13) | 0.93 |
| Model 2 | 1 (ref) | 0.92 (0.79–1.07) | 0.99 (0.85–1.16) | 1.00 (0.85–1.16) | 0.80 |
| Model 3 | 1 (ref) | 0.91 (0.78–1.07) | 0.98 (0.84–1.15) | 1.00 (0.85–1.17) | 0.82 |
| Model 4 | 1 (ref) | 0.91 (0.78–1.06) | 0.99 (0.85–1.15) | 1.00 (0.85–1.17) | 0.81 |
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 10.5 (<21.6) | 35.0 (21.6–50.8) | 68.0 (50.8–85.4) | 115.8 (≥85.4) | |
| Cases/ | 526/1695 | 495/1696 | 537/1696 | 506/1696 | |
| Model 1 | 1 (ref) | 0.94 (0.80–1.09) | 1.00 (0.86–1.17) | 0.98 (0.84–1.14) | 0.97 |
| Model 2 | 1 (ref) | 0.92 (0.79–1.07) | 1.00 (0.86–1.16) | 1.01 (0.86–1.17) | 0.70 |
| Model 3 | 1 (ref) | 0.92 (0.79–1.07) | 0.99 (0.85–1.15) | 1.01 (0.86–1.18) | 0.72 |
| Model 4 | 1 (ref) | 0.92 (0.79–1.07) | 0.99 (0.85–1.15) | 1.01 (0.86–1.18) | 0.71 |
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 0 | 0.3 (0.0–0.5) | 0.7 (0.5–1.0) | 1.5 (≥1.0) | |
| Cases/n | 1090/3,623 | 319/1,053 | 333/1,054 | 322/1,053 | |
| Model 1 | 1 (ref) | 0.98 (0.84–1.14) | 1.14 (0.98–1.33) | 1.14 (0.97–1.33) | 0.05 |
| Model 2 | 1 (ref) | 0.97 (0.83–1.13) | 1.11 (0.95–1.30) | 1.14 (0.97–1.33) | 0.07 |
| Model 3 | 1 (ref) | 0.96 (0.82–1.12) | 1.11 (0.95–1.30) | 1.15 (0.98–1.35) | 0.05 |
| Model 4 | 1 (ref) | 0.96 (0.82–1.12) | 1.10 (0.94–1.29) | 1.15 (0.98–1.34) | 0.06 |
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 0 (<0.7) | 1.7 (0.8–3.3) | 4.0 (3.3–6.7) | 14.3 (≥6.8) | |
| Cases/n | 466/1,701 | 442/1,502 | 629/2,015 | 527/1,565 | |
| Model 1 | 1 (ref) | 1.11 (0.95–1.30) | 1.18 (1.01–1.36) | 1.28 (1.09–1.50) |
|
| Model 2 | 1 (ref) | 1.09 (0.93–1.28) | 1.14 (0.97–1.32) | 1.21 (1.02–1.42) |
|
| Model 3 | 1 (ref) | 1.09 (0.93–1.29) | 1.14 (0.98–1.33) | 1.20 (1.02–1.42) |
|
| Model 4 | 1 (ref) | 1.09 (0.93–1.28) | 1.13 (0.97–1.32) | 1.20 (1.02–1.42) |
|
|
| |||||
| Median (cut points, g⋅2,000 kcal–1⋅d–1) | 1.6 (<3.3) | 6.7 (3.5–10.7) | 14.3 (11.4–20.8) | 33.3 (≥21.4) | |
| Cases/ | 568/1,950 | 418/1,436 | 494/1,585 | 584/1,812 | |
| Model 1 | 1 (ref) | 1.05 (0.89–1.22) | 1.12 (0.96–1.30) | 1.18 (1.02–1.37) |
|
| Model 2 | 1 (ref) | 1.05 (0.90–1.23) | 1.09 (0.93–1.27) | 1.13 (0.97–1.31) | 0.11 |
| Model 3 | 1 (ref) | 1.05 (0.90–1.23) | 1.10 (0.94–1.29) | 1.13 (0.97–1.32) | 0.10 |
| Model 4 | 1 (ref) | 1.05 (0.89–1.23) | 1.10 (0.94–1.28) | 1.13 (0.97–1.31) | 0.11 |